Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 75,400 | 70,502 | 70,162 | 64,850 | 59,757 |
| Cost of Goods | 1,707 | 246 | 199 | 276 | 346 |
| Gross Profit | 73,693 | 70,256 | 69,963 | 64,574 | 59,411 |
| Operating Expenses | 90,417 | 96,992 | 87,214 | 78,994 | 73,514 |
| Operating Income | -16,017 | -26,490 | -17,052 | -14,144 | -13,757 |
| Interest Expense | 4,277 | 3,239 | 1,309 | 1,321 | 1,274 |
| Other Income | 10,164 | 5,650 | -7,281 | 16,196 | -1,792 |
| Pre-tax Income | -10,130 | -24,079 | -25,642 | 731 | -16,823 |
| Income Tax | 1,486 | 357 | -5,912 | -175 | 191 |
| Net Income Continuous | -11,616 | -24,436 | -19,730 | 906 | -17,014 |
| Net Income | $-11,616 | $-24,436 | $-19,730 | $906 | $-17,014 |
| EPS Basic Total Ops | -0.23 | -0.49 | -0.40 | 0.02 | -0.35 |
| EPS Basic Continuous Ops | -0.23 | -0.49 | -0.40 | 0.02 | -0.35 |
| EPS Diluted Total Ops | -0.23 | -0.49 | -0.40 | 0.02 | -0.35 |
| EPS Diluted Continuous Ops | -0.23 | -0.49 | -0.39 | 0.02 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.49 | -0.40 | N/A | N/A |
| EBITDA(a) | $-15,025 | $-25,479 | $-16,020 | $-13,067 | $-12,728 |